Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression.
about
Studies of the central neural pathways to the stomach and Zusanli (ST36).Vaccinia virus vectors: new strategies for producing recombinant vaccines.Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.Molecular attenuation of vaccinia virus: mutant generation and animal characterizationAntigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive seraHerpes simplex virus type 1 DNA synthesis requires the product of the UL8 gene: isolation and characterization of an ICP6::lacZ insertion mutation.Isolation and characterization of herpes simplex virus mutants containing engineered mutations at the DNA polymerase locus.Transient dominant selection of recombinant vaccinia viruses.Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant.Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding proteinEscherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.An ICP6::lacZ insertional mutagen is used to demonstrate that the UL52 gene of herpes simplex virus type 1 is required for virus growth and DNA synthesisGenetically engineered poxviruses for recombinant gene expression, vaccination, and safetyVaccinia virus: a tool for research and vaccine development.An efficient method for generating poxvirus recombinants in the absence of selectionIsolation of a Marek's disease virus (MDV) recombinant containing the lacZ gene of Escherichia coli stably inserted within the MDV US2 gene.Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants.Construction of fowlpox virus vectors with intergenic insertions: expression of the beta-galactosidase gene and the measles virus fusion gene.Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.Vaccinia virus recombinants expressing an 11-kilodalton beta-galactosidase fusion protein incorporate active beta-galactosidase in virus particles.Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones.Use of early baculovirus promoters for continuous expression and efficient processing of foreign gene products in stably transformed lepidopteran cells.Methodology for the efficient generation of fluorescently tagged vaccinia virus proteins.
P2860
Q31005052-99598A0E-FF0F-45B1-A9E0-5C9FA5339E85Q34211635-79C2A222-F39F-42EC-B68D-E78DFC998F69Q34350358-BC49D62C-BBF0-422E-B39F-12FB2DF68F5AQ36696588-2C8C7DB3-652F-4446-980B-16A7AE4B44A7Q36780567-D49E751E-9E43-4BB5-AF94-0032581DDD9DQ36780584-27014426-E4F0-4688-A81A-6012C72E1822Q36805852-7F8349B5-0592-4806-9391-F67860F73CBEQ36808769-26DCAA2E-6C38-4A97-823D-9EC3C7F96356Q36826076-EF09C0A3-1A00-46D9-BCA5-7EC743577DB4Q36830970-D6B85014-AFBB-4485-9887-88F4FAEA946DQ36832257-7DA68EE8-0A6F-4AC3-BA3F-2EFCD496731FQ36868255-E3DC7E6D-1725-4F19-88C1-886EC6E522FEQ36879223-E1D4DB26-DF50-44D0-8282-242D5AFFAAB0Q37249251-4B5AAA9C-E027-4B32-8147-8F226F6CE0D7Q37755852-D0C1A65C-E885-4F5A-93FF-176A437B6E24Q39558525-1369F394-F08E-4197-97D9-97BA4EE2A004Q40059668-C7FC3DEB-9E6D-44AC-8CA4-6F42EE6ED6ADQ40065736-2F3357E0-870B-47C1-8EDD-2B7B77B99265Q40107685-451E8784-BD66-4736-9C0C-C47B909D9DCDQ40108953-36E45475-88E2-4053-AA87-BED76F2C1118Q40116789-E41A591D-A1A8-4565-9D81-17835B7FF5ACQ40129351-5C0BC843-276A-4466-BD0D-096AF767BA09Q40308752-17E22E46-6782-41A9-BBAD-071E15159BC4Q41721001-D59F36C3-8BB2-46BB-84F2-13C5FD628B55Q42019117-484A28D3-315A-4020-A4DD-5C31A35606B6
P2860
Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Vaccinia virus vectors utilizi ...... easurement of gene expression.
@en
Vaccinia virus vectors utilizi ...... easurement of gene expression.
@nl
type
label
Vaccinia virus vectors utilizi ...... easurement of gene expression.
@en
Vaccinia virus vectors utilizi ...... easurement of gene expression.
@nl
prefLabel
Vaccinia virus vectors utilizi ...... easurement of gene expression.
@en
Vaccinia virus vectors utilizi ...... easurement of gene expression.
@nl
P2093
P1433
P1476
Vaccinia virus vectors utilizi ...... easurement of gene expression.
@en
P2093
P304
P356
10.1016/0378-1119(86)90063-6
P407
P577
1986-01-01T00:00:00Z